Macroglobulinèmia de Waldenström (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Macroglobulinèmia de Waldenström" in Catalan language version.

refsWebsite

Global rank Catalan rank

22doi.org

2^nd place

6^th place

17nih.gov

4^th place

7^th place

9web.archive.org

1^st place

8worldcat.org

5^th place

7mirbase.org

low place

3medscape.com

719^th place

610^th place

2bloodjournal.org

low place

2clinicaltrials.gov

5,225^th place

7,558^th place

1cell.com

2,814^th place

960^th place

1asco.org

low place

1aacrjournals.org

8,869^th place

2,921^st place

1nature.com

234^th place

127^th place

1seminoncol.org

low place

1expertconsultbook.com

low place

1cancer.gov

1,684^th place

1,053^rd place

1wiley.com

222^nd place

128^th place

aacrjournals.org

cancerres.aacrjournals.org

Braggio, Esteban; Keats, Jonathan J.; Leleu, Xavier; Wier, Scott Van; Jimenez-Zepeda, Victor H. «Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenström's Macroglobulinemia» (en anglès). Cancer Research, 69, 8, 15-04-2009, pàg. 3579–3588. DOI: 10.1158/0008-5472.CAN-08-3701. ISSN: 0008-5472. PMID: 19351844.

asco.org

«Meeting Library Redesign» (en anglès). ASCO, 26-05-2017.^{[Enllaç no actiu]}

bloodjournal.org

Leleu, Xavier; Jia, Xiaoying; Runnels, Judith; Ngo, Hai T.; Moreau, Anne-Sophie «The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia» (en anglès). Blood, 110, 13, 15-12-2007, pàg. 4417–4426. DOI: 10.1182/blood-2007-05-092098. ISSN: 0006-4971. PMID: 17761832.
Roccaro, Aldo M.; Sacco, Antonio; Chen, Changzhong; Runnels, Judith; Leleu, Xavier «microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia» (en anglès). Blood, 113, 18, 30-04-2009, pàg. 4391–4402. DOI: 10.1182/blood-2008-09-178228. ISSN: 0006-4971. PMID: 19074725.

cancer.gov

National Cancer Institute. Waldenström Macroglobulinemia: Questions and Answers Arxivat 2013-01-28 a Wayback Machine.. Retrieved on: 2011-08-14.

cell.com

McMaster, Mary L.; Goldin, Lynn R.; Bai, Yan; Ter-Minassian, Monica; Boehringer, Stefan «Genomewide Linkage Screen for Waldenström Macroglobulinemia Susceptibility Loci in High-Risk Families» (en anglès). The American Journal of Human Genetics, 79, 4, 2006-10, pàg. 695–701. DOI: 10.1086/507687. ISSN: 0002-9297.

clinicaltrials.gov

«Search of: Waldenstrom - List Results - ClinicalTrials.gov» (en anglès). .
«Search of: Waldenstrom | Interventional Studies | Phase 2 - List Results - ClinicalTrials.gov» (en anglès). .

doi.org

dx.doi.org

Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD «The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997». Histopathology, 36, 1, 2000, pàg. 69–86. DOI: 10.1046/j.1365-2559.2000.00895.x. PMID: 10632755.
Schop RF; Ghobrial, I; Ahmann, G; Greipp, P; Kyle, R; Dispenzieri, A; Lacy, M; Van Wier SA; Xu R; 3 «6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance». Cancer Genet. Cytogenet., 169, 2, 2006, pàg. 150–3. DOI: 10.1016/j.cancergencyto.2006.04.009. PMID: 16938573.
McMaster, Mary L.; Goldin, Lynn R.; Bai, Yan; Ter-Minassian, Monica; Boehringer, Stefan «Genomewide Linkage Screen for Waldenström Macroglobulinemia Susceptibility Loci in High-Risk Families» (en anglès). The American Journal of Human Genetics, 79, 4, 2006-10, pàg. 695–701. DOI: 10.1086/507687. ISSN: 0002-9297.
Sacco, Antonio; Issa, Ghayas C.; Zhang, Yong; Liu, Yang; Maiso, Patricia «Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology». Journal of Hematology & Oncology, 3, 07-10-2010, pàg. 38. DOI: 10.1186/1756-8722-3-38. ISSN: 1756-8722.
Leleu, Xavier; Jia, Xiaoying; Runnels, Judith; Ngo, Hai T.; Moreau, Anne-Sophie «The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia» (en anglès). Blood, 110, 13, 15-12-2007, pàg. 4417–4426. DOI: 10.1182/blood-2007-05-092098. ISSN: 0006-4971. PMID: 17761832.
Braggio, Esteban; Keats, Jonathan J.; Leleu, Xavier; Wier, Scott Van; Jimenez-Zepeda, Victor H. «Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenström's Macroglobulinemia» (en anglès). Cancer Research, 69, 8, 15-04-2009, pàg. 3579–3588. DOI: 10.1158/0008-5472.CAN-08-3701. ISSN: 0008-5472. PMID: 19351844.
Gutiérrez, N C; Ocio, E M; de las Rivas, J; Maiso, P; Delgado, M «Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals» (en anglès). Leukemia, 21, 3, 25-01-2007, pàg. 541–549. DOI: 10.1038/sj.leu.2404520. ISSN: 0887-6924.
Roccaro, Aldo M.; Sacco, Antonio; Chen, Changzhong; Runnels, Judith; Leleu, Xavier «microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia» (en anglès). Blood, 113, 18, 30-04-2009, pàg. 4391–4402. DOI: 10.1182/blood-2008-09-178228. ISSN: 0006-4971. PMID: 19074725.
Treon, Steven P.; Kelliher, Abigail; Keele, Beverly; Frankel, Stanley; Emmanouilides, Christos «Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: Therapeutic applications and considerations» (en anglès). Seminars in Oncology, 30, 2, 2003-04, pàg. 248–252. DOI: 10.1053/sonc.2003.50047. ISSN: 0093-7754.
Owen RG, Barrans SL, Richards SJ, O'Connor SJ, Child JA, Parapia LA, Morgan GJ, Jack AS; Richards; O'Connor; Morgan; Owen; Parapia; Jack «Waldenstrom macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors». Am J Clin Pathol, 116, 3, 2001, pàg. 420–8. DOI: 10.1309/4LCN-JMPG-5U71-UWQB. PMID: 11554171.
San Miguel JF, Vidriales MB, Ocio E, Mateo G, Sanchez-Guijo F, Sanchez ML, Escribano L, Barez A, Moro MJ, Hernandez J, Aguilera C, Cuello R, Garcia-Frade J, Lopez R, Portero J, Orfao A «Immunophenotypic analysis of Waldenstrom's macroglobulinemia». Semin Oncol, 30, 2, 2003, pàg. 187–95. DOI: 10.1053/sonc.2003.50074. PMID: 12720134.
Ghobrial IM, Witzig TE «Waldenstrom macroglobulinemia». Curr Treat Options Oncol, 5, 3, 2004, pàg. 239–47. DOI: 10.1007/s11864-004-0015-5. PMC: 3133652. PMID: 15115652.
Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP «Diagnosis and management of Waldenstrom's macroglobulinemia». J Clin Oncol, 23, 7, 2005, pàg. 1564–77. DOI: 10.1200/JCO.2005.03.144. PMID: 15735132.
Waldenström J «To treat or not to treat, this is the real question». Leuk Res, 15, 6, 1991, pàg. 407–8. DOI: 10.1016/0145-2126(91)90049-Y. PMID: 1907339.
Kyle RA, Treon SP, Alexanian R, Barlogie B, Bjorkholm M, Dhodapkar M, Lister TA, Merlini G, Morel P, Stone M, Branagan AR, Leblond V «Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia». Semin Oncol, 30, 2, 2003, pàg. 116–20. DOI: 10.1053/sonc.2003.50038. PMID: 12720119.
Gertz MA «Waldenstrom macroglobulinemia: a review of therapy». Am J Hematol, 79, 2, 2005, pàg. 147–57. DOI: 10.1002/ajh.20363. PMID: 15929102.
Yang L, Wen B, Li H, Yang M, Jin Y, Yang S, Tao J «Autologous peripheral blood stem cell transplantation for Waldenstrom's macroglobulinemia». Bone Marrow Transplant, 24, 8, 1999, pàg. 929–30. DOI: 10.1038/sj.bmt.1701992. PMID: 10516708.
Martino R, Shah A, Romero P, Brunet S, Sierra J, Domingo-Albos A, Fruchtman S, Isola L «Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia». Bone Marrow Transplant, 23, 7, 1999, pàg. 747–9. DOI: 10.1038/sj.bmt.1701633. PMID: 10218857.
Anagnostopoulos A, Dimopoulos MA, Aleman A, Weber D, Alexanian R, Champlin R, Giralt S «High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia». Bone Marrow Transplant, 27, 10, 2001, pàg. 1027–9. DOI: 10.1038/sj.bmt.1703041. PMID: 11438816.
Tournilhac O, Leblond V, Tabrizi R, Gressin R, Senecal D, Milpied N, Cazin B, Divine M, Dreyfus B, Cahn JY, Pignon B, Desablens B, Perrier JF, Bay JO, Travade P «Transplantation in Waldenstrom's macroglobulinemia--the French experience». Semin Oncol, 30, 2, 2003, pàg. 291–6. DOI: 10.1053/sonc.2003.50048. PMID: 12720155.
Treon, Steven P.; Yang, Guang; Hanzis, Christine; Ioakimidis, Leukothea «Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia» (en anglès). British Journal of Haematology, 154, 2, 12-05-2011, p. 223–228. DOI: 10.1111/j.1365-2141.2011.08726.x. ISSN: 0007-1048.

doi.org

Sacco, Antonio; Issa, Ghayas C.; Zhang, Yong; Liu, Yang; Maiso, Patricia «Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology». Journal of Hematology & Oncology, 3, 07-10-2010, pàg. 38. DOI: 10.1186/1756-8722-3-38. ISSN: 1756-8722.

expertconsultbook.com

Morbidity Mediated By The Effects Of IgM Arxivat 2012-03-26 a Wayback Machine. From Chapter 88 - Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma. Hoffman, Ronald. Hematology : basic principles and practic. Philadelphia, PA: Churchill Livingstone/Elsevier, 2009. ISBN 978-0-443-06715-0.

medscape.com

emedicine.medscape.com

Ponce, D. Waldenstrom Hypergammaglobulinemia Workup. Medscape. Retrieved on: 2011-08-14.
^{[enllaç sense format]} http://emedicine.medscape.com/article/207097-overview
^{[enllaç sense format]} http://emedicine.medscape.com/article/207097-treatment

mirbase.org

«miRNA Entry for MI0000764». Arxivat de l'original el 2018-04-23. [Consulta: 22 abril 2018].
«miRNA Entry for MI0000490». Arxivat de l'original el 2021-01-19. [Consulta: 22 abril 2018].
«miRNA Entry for MI0003134». Arxivat de l'original el 2021-07-27. [Consulta: 22 abril 2018].
«miRNA Entry for MI0000681». Arxivat de l'original el 2021-06-04. [Consulta: 22 abril 2018].
«miRNA Entry for MI0000481». Arxivat de l'original el 2020-09-25. [Consulta: 22 abril 2018].
«miRNA Entry for MI0003686». Arxivat de l'original el 2020-12-04. [Consulta: 22 abril 2018].
«miRNA Entry for MI0000466». Arxivat de l'original el 2021-06-04. [Consulta: 22 abril 2018].

nature.com

Gutiérrez, N C; Ocio, E M; de las Rivas, J; Maiso, P; Delgado, M «Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals» (en anglès). Leukemia, 21, 3, 25-01-2007, pàg. 541–549. DOI: 10.1038/sj.leu.2404520. ISSN: 0887-6924.

nih.gov

ncbi.nlm.nih.gov

Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD «The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997». Histopathology, 36, 1, 2000, pàg. 69–86. DOI: 10.1046/j.1365-2559.2000.00895.x. PMID: 10632755.
Schop RF; Ghobrial, I; Ahmann, G; Greipp, P; Kyle, R; Dispenzieri, A; Lacy, M; Van Wier SA; Xu R; 3 «6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance». Cancer Genet. Cytogenet., 169, 2, 2006, pàg. 150–3. DOI: 10.1016/j.cancergencyto.2006.04.009. PMID: 16938573.
Leleu, Xavier; Jia, Xiaoying; Runnels, Judith; Ngo, Hai T.; Moreau, Anne-Sophie «The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia» (en anglès). Blood, 110, 13, 15-12-2007, pàg. 4417–4426. DOI: 10.1182/blood-2007-05-092098. ISSN: 0006-4971. PMID: 17761832.
Braggio, Esteban; Keats, Jonathan J.; Leleu, Xavier; Wier, Scott Van; Jimenez-Zepeda, Victor H. «Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenström's Macroglobulinemia» (en anglès). Cancer Research, 69, 8, 15-04-2009, pàg. 3579–3588. DOI: 10.1158/0008-5472.CAN-08-3701. ISSN: 0008-5472. PMID: 19351844.
Roccaro, Aldo M.; Sacco, Antonio; Chen, Changzhong; Runnels, Judith; Leleu, Xavier «microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia» (en anglès). Blood, 113, 18, 30-04-2009, pàg. 4391–4402. DOI: 10.1182/blood-2008-09-178228. ISSN: 0006-4971. PMID: 19074725.
Owen RG, Barrans SL, Richards SJ, O'Connor SJ, Child JA, Parapia LA, Morgan GJ, Jack AS; Richards; O'Connor; Morgan; Owen; Parapia; Jack «Waldenstrom macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors». Am J Clin Pathol, 116, 3, 2001, pàg. 420–8. DOI: 10.1309/4LCN-JMPG-5U71-UWQB. PMID: 11554171.
San Miguel JF, Vidriales MB, Ocio E, Mateo G, Sanchez-Guijo F, Sanchez ML, Escribano L, Barez A, Moro MJ, Hernandez J, Aguilera C, Cuello R, Garcia-Frade J, Lopez R, Portero J, Orfao A «Immunophenotypic analysis of Waldenstrom's macroglobulinemia». Semin Oncol, 30, 2, 2003, pàg. 187–95. DOI: 10.1053/sonc.2003.50074. PMID: 12720134.
Ghobrial IM, Witzig TE «Waldenstrom macroglobulinemia». Curr Treat Options Oncol, 5, 3, 2004, pàg. 239–47. DOI: 10.1007/s11864-004-0015-5. PMC: 3133652. PMID: 15115652.
Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP «Diagnosis and management of Waldenstrom's macroglobulinemia». J Clin Oncol, 23, 7, 2005, pàg. 1564–77. DOI: 10.1200/JCO.2005.03.144. PMID: 15735132.
Johansson B, Waldenstrom J, Hasselblom S, Mitelman F «Waldenstrom's macroglobulinemia with the AML/MDS-associated t(1;3)(p36;q21)». Leukemia, 9, 7, 1995, pàg. 1136–8. PMID: 7630185.
Waldenström J «To treat or not to treat, this is the real question». Leuk Res, 15, 6, 1991, pàg. 407–8. DOI: 10.1016/0145-2126(91)90049-Y. PMID: 1907339.
Kyle RA, Treon SP, Alexanian R, Barlogie B, Bjorkholm M, Dhodapkar M, Lister TA, Merlini G, Morel P, Stone M, Branagan AR, Leblond V «Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia». Semin Oncol, 30, 2, 2003, pàg. 116–20. DOI: 10.1053/sonc.2003.50038. PMID: 12720119.
Gertz MA «Waldenstrom macroglobulinemia: a review of therapy». Am J Hematol, 79, 2, 2005, pàg. 147–57. DOI: 10.1002/ajh.20363. PMID: 15929102.
Yang L, Wen B, Li H, Yang M, Jin Y, Yang S, Tao J «Autologous peripheral blood stem cell transplantation for Waldenstrom's macroglobulinemia». Bone Marrow Transplant, 24, 8, 1999, pàg. 929–30. DOI: 10.1038/sj.bmt.1701992. PMID: 10516708.
Martino R, Shah A, Romero P, Brunet S, Sierra J, Domingo-Albos A, Fruchtman S, Isola L «Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia». Bone Marrow Transplant, 23, 7, 1999, pàg. 747–9. DOI: 10.1038/sj.bmt.1701633. PMID: 10218857.
Anagnostopoulos A, Dimopoulos MA, Aleman A, Weber D, Alexanian R, Champlin R, Giralt S «High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia». Bone Marrow Transplant, 27, 10, 2001, pàg. 1027–9. DOI: 10.1038/sj.bmt.1703041. PMID: 11438816.
Tournilhac O, Leblond V, Tabrizi R, Gressin R, Senecal D, Milpied N, Cazin B, Divine M, Dreyfus B, Cahn JY, Pignon B, Desablens B, Perrier JF, Bay JO, Travade P «Transplantation in Waldenstrom's macroglobulinemia--the French experience». Semin Oncol, 30, 2, 2003, pàg. 291–6. DOI: 10.1053/sonc.2003.50048. PMID: 12720155.

seminoncol.org

Treon, Steven P.; Kelliher, Abigail; Keele, Beverly; Frankel, Stanley; Emmanouilides, Christos «Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: Therapeutic applications and considerations» (en anglès). Seminars in Oncology, 30, 2, 2003-04, pàg. 248–252. DOI: 10.1053/sonc.2003.50047. ISSN: 0093-7754.

web.archive.org

«miRNA Entry for MI0000764». Arxivat de l'original el 2018-04-23. [Consulta: 22 abril 2018].
«miRNA Entry for MI0000490». Arxivat de l'original el 2021-01-19. [Consulta: 22 abril 2018].
«miRNA Entry for MI0003134». Arxivat de l'original el 2021-07-27. [Consulta: 22 abril 2018].
«miRNA Entry for MI0000681». Arxivat de l'original el 2021-06-04. [Consulta: 22 abril 2018].
«miRNA Entry for MI0000481». Arxivat de l'original el 2020-09-25. [Consulta: 22 abril 2018].
«miRNA Entry for MI0003686». Arxivat de l'original el 2020-12-04. [Consulta: 22 abril 2018].
«miRNA Entry for MI0000466». Arxivat de l'original el 2021-06-04. [Consulta: 22 abril 2018].
Morbidity Mediated By The Effects Of IgM Arxivat 2012-03-26 a Wayback Machine. From Chapter 88 - Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma. Hoffman, Ronald. Hematology : basic principles and practic. Philadelphia, PA: Churchill Livingstone/Elsevier, 2009. ISBN 978-0-443-06715-0.
National Cancer Institute. Waldenström Macroglobulinemia: Questions and Answers Arxivat 2013-01-28 a Wayback Machine.. Retrieved on: 2011-08-14.

wiley.com

onlinelibrary.wiley.com

Treon, Steven P.; Yang, Guang; Hanzis, Christine; Ioakimidis, Leukothea «Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia» (en anglès). British Journal of Haematology, 154, 2, 12-05-2011, p. 223–228. DOI: 10.1111/j.1365-2141.2011.08726.x. ISSN: 0007-1048.

worldcat.org

McMaster, Mary L.; Goldin, Lynn R.; Bai, Yan; Ter-Minassian, Monica; Boehringer, Stefan «Genomewide Linkage Screen for Waldenström Macroglobulinemia Susceptibility Loci in High-Risk Families» (en anglès). The American Journal of Human Genetics, 79, 4, 2006-10, pàg. 695–701. DOI: 10.1086/507687. ISSN: 0002-9297.
Sacco, Antonio; Issa, Ghayas C.; Zhang, Yong; Liu, Yang; Maiso, Patricia «Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology». Journal of Hematology & Oncology, 3, 07-10-2010, pàg. 38. DOI: 10.1186/1756-8722-3-38. ISSN: 1756-8722.
Leleu, Xavier; Jia, Xiaoying; Runnels, Judith; Ngo, Hai T.; Moreau, Anne-Sophie «The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia» (en anglès). Blood, 110, 13, 15-12-2007, pàg. 4417–4426. DOI: 10.1182/blood-2007-05-092098. ISSN: 0006-4971. PMID: 17761832.
Braggio, Esteban; Keats, Jonathan J.; Leleu, Xavier; Wier, Scott Van; Jimenez-Zepeda, Victor H. «Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenström's Macroglobulinemia» (en anglès). Cancer Research, 69, 8, 15-04-2009, pàg. 3579–3588. DOI: 10.1158/0008-5472.CAN-08-3701. ISSN: 0008-5472. PMID: 19351844.
Gutiérrez, N C; Ocio, E M; de las Rivas, J; Maiso, P; Delgado, M «Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals» (en anglès). Leukemia, 21, 3, 25-01-2007, pàg. 541–549. DOI: 10.1038/sj.leu.2404520. ISSN: 0887-6924.
Roccaro, Aldo M.; Sacco, Antonio; Chen, Changzhong; Runnels, Judith; Leleu, Xavier «microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia» (en anglès). Blood, 113, 18, 30-04-2009, pàg. 4391–4402. DOI: 10.1182/blood-2008-09-178228. ISSN: 0006-4971. PMID: 19074725.
Treon, Steven P.; Kelliher, Abigail; Keele, Beverly; Frankel, Stanley; Emmanouilides, Christos «Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: Therapeutic applications and considerations» (en anglès). Seminars in Oncology, 30, 2, 2003-04, pàg. 248–252. DOI: 10.1053/sonc.2003.50047. ISSN: 0093-7754.
Treon, Steven P.; Yang, Guang; Hanzis, Christine; Ioakimidis, Leukothea «Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia» (en anglès). British Journal of Haematology, 154, 2, 12-05-2011, p. 223–228. DOI: 10.1111/j.1365-2141.2011.08726.x. ISSN: 0007-1048.